SPIN SIGNAL
DEAD

Serial Number

78091167

Owner

AMERSHAM PLC

Attorney

Catherine Mennenga

Filing Date

Nov 1, 2001

Add to watchlist:

No watchlists yet
View on USPTO

SPIN SIGNAL Trademark

Serial Number: 78091167

SPIN SIGNAL is a trademark filed by AMERSHAM PLC on November 1, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

AMERSHAM PLC (44 trademarks)

BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 03

GE HEALTHCARE LIMITED (94 trademarks)

AMERSHAM PLACE LITTLE CHALFONT
BUCKINGHAMSHIRE HP7 9NA , GB

Entity Type: 99

Trademark Details

Filing Date

November 1, 2001

Registration Date

Not Registered

Published for Opposition

December 17, 2002

Goods & Services

Educational services, namely training services and conducting classes and seminars in the field of medical imaging and diagnostics; holding seminars, conferences, symposiums and workshops relating to the pharmaceutical industry, for medical practitioners and employees of pharmaceutical companies.

Scientific apparatus and instruments for use in measuring, monitoring and surveying, namely, computers, printers, and computer software programs for use in life science research and data analysis, namely, detecting and monitoring radiation, radioactivity, and radioactive contamination, and for nuclear cardiology and medical imaging, for use by laboratories; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely, automated film readers and scanners; apparatus for electrophoresis comprised of gel separation units, power/control units, gel cassettes, tanks, and casting, running and blotting modules; chromatography columns and pumps; scientific apparatus for microfabrication comprised of scanners and imagers; apparatus for scintillation imaging cameras and scintillation counters; synthesis and purification integrated systems comprised of chromatography monitors, computer hardware and data processing software for use in radiology; imaging apparatus for radioactive and luminescent emissions for use in radiology; imaging apparatus for radioactive and luminescent emissions for use in radiology; apparatus for use in the manufacturing of oligonucleotides, comprised of synthesizers and purifiers; apparatus for microarrays, comprised of array spotters, array scanners, slide processors and hybridation buffers; microarray slides; glassware, namely, glass tubes, vials, microvials, and microplates for scientific purposes; and parts and fittings for the aforesaid goods; diagnostic and test kits for medical use comprised of test tubes, test plates and indicator charts for evaluating test results

Contrast media for medical imaging; diagnostic scanning agents, gases and gas mixtures for medical imaging, and reagents for in vivo clinical use; radiopharmaceutical products, namely, radioactive compounds for use in diagnostic imaging for clinical, medical, scientific, and research use; radioactive sources and standards, namely, radioisotope brachytherapy sources and radioactive compounds for use as calibration standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic and therapeutic use; pharmaceutical preparations, namely, reagents for use in medical diagnosis; pre-filled vials containing medical diagnostic reagents; pre-filled cartridges containing saline solution

Chemicals, biochemicals and reagents for use in industry, science, and research, namely, nucleotides, fluorescent nucleotides, oligonucleotides, peptides, proteins, amino acids, organic molecules, chemical markers for DNA and RNA synthesis; reagents for luminescence; reagents for gene expression quantification; reagents for use with the polymerase reaction, PCR, process and RCA, rolling circle amplication process; reagents for cDNA cloning vectors, modifying and restriction enzymes; reagents for labeling, sequencing and fragment analysis of nucleic acids, proteins and custom synthesis; reagents for recombinant protein expression purification, chromatography media, electrophoresis, spectrophotometry and fluorometry; radiochemicals; scintillation assays; and high through put screening assays for drug development; chemical preparations and substances for use in the manufacture of pharmaceutical products; diagnostic preparations and substances for scientific and research use; chemical test reagents, saline solution and reagent-coated paper all for scientific and laboratory use; fissionable chemical elements; radioactive elements, isotopes, preparations, and reagents for industrial, scientific, and research purposes; kits consisting primarily of chemical preparations and reagents for analysis and diagnosis used for scientific purposes, namely, cell separation and culture, nucleic acid purification; radionuclides; and gases and gas mixtures for industrial, scientific, and research purposes

Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, namely, medical needles, suture needles, implantable radiation therapy devices and implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography apparatus, CAT scan apparatus; scanners and ultrasound diagnostic apparatus; cannulas; vial access cannulas; needles and syringes for medical use; injectors for medical use; cartridges for medical use; infusion pumps for intravenous administration of fluids; imaging apparatus for radioactive and luminescent emissions for use in radiology; and parts and fittings for the aforesaid goods

Pharmaceutical advice, consultancy, and analytical services relating to chemical and pharmaceutical research for pharmaceutical companies in the field of purification and chromatography; development services in the fields of pharmaceuticals, life sciences, medicine and biochemistry; product research and development for others, namely research and development of pharmaceutical, medical, and veterinary preparations, diagnostic media and agents for use in medical and diagnostic imaging; providing medical information and medicinal information, namely, information regarding pharmacological properties to pharmaceutical companies and medical professionals; medical laboratory services, namely, medical diagnostic services, and medical imaging services; radiolabeling services, namely isotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionals

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 17, 2006 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 17, 2006 ABN6
SOU EXTENSION 5 GRANTED
Sep 19, 2005 EX5G
SOU TEAS EXTENSION RECEIVED
Sep 12, 2005 EEXT
SOU TEAS EXTENSION RECEIVED
Sep 12, 2005 EEXT
SOU EXTENSION 5 FILED
Sep 11, 2005 EXT5
SOU EXTENSION 4 GRANTED
Apr 4, 2005 EX4G
SOU EXTENSION 4 FILED
Mar 8, 2005 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 8, 2005 EEXT
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 17, 2005 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 17, 2005 REAP
SOU EXTENSION 3 GRANTED
Sep 23, 2004 EX3G
SOU TEAS EXTENSION RECEIVED
Sep 13, 2004 EEXT
SOU EXTENSION 3 FILED
Sep 11, 2004 EXT3
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 24, 2004 TROA
CASE FILE IN TICRS
Aug 11, 2004 CFIT
SOU EXTENSION 2 GRANTED
Feb 4, 2004 EX2G
SOU EXTENSION 2 FILED
Jan 12, 2004 EXT2
SOU TEAS EXTENSION RECEIVED
Jan 12, 2004 EEXT
PAPER RECEIVED
Sep 22, 2003 MAIL
SOU EXTENSION 1 GRANTED
Sep 2, 2003 EX1G
SOU EXTENSION 1 FILED
Aug 7, 2003 EXT1
PAPER RECEIVED
Aug 7, 2003 MAIL
PAPER RECEIVED
Apr 1, 2003 MAIL
NOA MAILED - SOU REQUIRED FROM APPLICANT
Mar 11, 2003 NOAM
PAPER RECEIVED
Dec 18, 2002 MAIL
PUBLISHED FOR OPPOSITION
Dec 17, 2002 PUBO
NOTICE OF PUBLICATION
Nov 27, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 17, 2002 CNSA
EXAMINERS AMENDMENT E-MAILED
Oct 17, 2002 GNEA
ASSIGNED TO EXAMINER
Oct 15, 2002 DOCK
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Oct 15, 2002 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2002 CRFA
PAPER RECEIVED
Jul 15, 2002 MAIL
FINAL REFUSAL E-MAILED
May 17, 2002 GNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 5, 2002 CRFA
PAPER RECEIVED
Apr 5, 2002 MAIL
NON-FINAL ACTION E-MAILED
Feb 9, 2002 GNRT
ASSIGNED TO EXAMINER
Jan 30, 2002 DOCK